Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Jan 03, 2012 Nature speaks with Keim about H5N1 studies Tags: h5n1, northern arizona university, paul keim, tgen north -
-
-
Jun 20, 2011 Promising skin-cancer drug nears approval Tags: daniel von hoff, scottsdale healthcare, tgen
Tumor-sensitizing drugs may enhance cancer therapy
Tags: bio5, cancer, university of arizona[Sourve: Oncology Nursing News] - Research conducted at The University of Arizona suggests that a drug may be able to change the function of hard-to-treat tumor cells so they will be more responsive to chemotherapy or radiation.
To gain greater response rates on melanoma tumors in cell cultures, Randy Burd, PhD, assistant professor of nutritional sciences and member of The University of Arizona's BIO5 Institute, has been testing dacarbazine, the standard chemotherapeutic drug, along with its analog temozolomide, in combination with various bioactive compounds.
For more information: Tumor-Sensitizing Drugs May Enhance Cancer Therapy
Quick Links
![]()
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.


Share on Twitter
Share on Facebook


